Abstract:OBJECTIVES:To investigate the clinicopathological characteristics, human papillomavirus (HPV) infection, p53 expression, and TP53 mutations in oropharyngeal squamous cell carcinoma (OPSCC) and determine their utility as prognostic predictors in a primarily eastern Chinese population.METHODS:The HPV infection status was tested via p16INK4A immunohistochemistry and validated using PCR, reverse blot hybridization and in situ hybridization (ISH) in 188 OPSCC samples. p53 expression levels and TP53 gene mutations were assessed through immunohistochemistry and sequencing, respectively. Clinicopathological characteristics and follow-up information were collected. Overall survival was estimated using the Log-rank test.RESULTS:Overall, 22 of the 188 OPSCC samples were associated with HPV infection. HPV16 was identified in all 22 samples, whereas no samples were positive for HPV18. All 22 HPV-associated OPSCC samples were p53 negative and lacked TP53 mutations. HPV16 positivity, female patients, non-smokers, and patients with histological grade I and stage N0 diseases showed better overall survival (p = 0.009, 0.003, 0.048, 0.009, and 0.004, respectively). No significant differences in overall survival between smoking and non-smoking patients were observed in the HPV-associated OPSCC group. Patients without mutations in TP53 exons 5-8 had better prognoses (p = 0.031) among the 43 sequenced specimens. Multivariate analysis indicated that HPV16 infection status (p = 0.011), histological grade (p = 0.017), and N stage (p = 0.019) were independent prognostic factors for patients with OPSCC.CONCLUSIONS:Distinct from the situation in Europe and America, for the patients with OPSCC in this study, HPV16 infection was relatively low, although it was still the most important independent prognostic predictor for the disease. In addition to the high smoking and drinking rate in this population, HPV16 infection and TP53 dysfunction appear to be two distinct pathogens for OPSCC patients in the eastern Chinese population.

HPV infection and its effect on p53 mutation in oral squmous cell carinoma

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

[Expression and correlation of HPV16E6 and tumor suppressor gene p53 in oral squamous cell carcinoma]

P53 Codon 72 Polymorphism in Cervical Cancers and Its Correlation with HPV16,18E6

[Human Papillomavirus, Human Cytomegalovirus and P53 Gene in Cervical Carcinoma].

Expression and Effect of Human Papillomavirus in Esophageal Carcinoma

p16 and p53 Gene Expression in Oral Squamous Cell Carcinomas

The Related Study of High Risk HPVI6、18 Infection and Expression of Multiple Genes in Oral Squamous Cell Carcinomas

HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing P53 Expression Via Co-Repressor NCOR1

Analysis of TP53 Mutations and HPV Infection in Esophageal Cancer

[Relationship Between HPV-DNA Status and P16 Protein Expression in Oropharyngeal Squamous Cell Carcinoma and Their Clinical Significance].

Human papillomavirus infection and prognostic predictors in patients with oropharyngeal squamous cell carcinoma.

Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.

[Human Papillomavirus Infection in Oropharyngeal Squamous Cell Carcinoma and Prognosis: a Preliminary Analysis of 66 Cases].

Evaluation of HPV and EBV in OSCC and the expression of p53, p16, E-cadherin, COX-2, MYC, and MLH1

HPV16 E6 Mutations and P53 Codon72 Polymorphism among Women with Cervical Intraepithelial Neoplasia 2 and 3 in China.

Human papillomavirus-16 infection and p16 expression in oral squamous cell carcinoma

Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population

Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas.

Human papillomavirus type 16 and 18 DNA in oral squamous cell carcinoma and normal mucosa.